Preterm Delivery: Clinical Trials

4 trials for Preterm Delivery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Terminated 4
Phase 21Terminated 1

Follow Preterm Delivery: new trials by email Literature Review of Preterm Delivery trials Research Report on Preterm Delivery

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Correction of Neonatal Glutathione by N-acetylcysteine in Pregnant Women at Risk of Premature Birth (GSH MAP)
N-acetylcysteine, Placebo - Preterm Delivery
Phase 2 / Phase 3TerminatedNantes University Hospital392018-11-052022-12-19
A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix
Arabin Cervical Pessary - Short Cervix, Preterm Delivery
Phase 3TerminatedThe George Washington University Biostatistics Center5442017-02-142026-06-23
RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix
17 alpha-hydroxyprogesterone caproate, Placebo Oil - Preterm Delivery, Cervical Length
Phase 3TerminatedThe George Washington University Biostatistics Center6572007-04-012019-07-15
Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor
progesterone, placebo - Preterm Delivery, Morbidity
Phase 3Terminatedbegoña Martinez de Tejada3842006-07-012012-06-06

Narrower conditions

Premature Birth (4)  ·  Obstetric Labor, Premature (1)  ·  Perinatal Death (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (4)  ·  Obstetric Labor Complications (4)  ·  Pregnancy Complications (4)  ·  Urogenital Diseases (4)  ·  Obstetric Labor, Premature (3)  ·  Death (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

17 alpha-Hydroxyprogesterone Caproate (1)  ·  Acetylcysteine (1)  ·  Progesterone (1)  ·  Utrogestan (1)

Sponsors

The George Washington University Biostatistics Center (2)  ·  Nantes University Hospital (1)  ·  begoña Martinez de Tejada (1)

Countries

United States (2)  ·  Argentina (1)  ·  France (1)  ·  Switzerland (1)

Top investigators

Begona Martinez de Tejada, MD, PhD (1)  ·  Matthew Hoffman, MD (1)  ·  Menachem Miodovnik, MD (1)  ·  Monica Longo, MD (1)  ·  Rebecca Clifton, Ph.D. (1)  ·  William Grobman, MD, MBA (1)

Results publications

PMID 23010094, PMID 25209926, PMID 37490086, PMID 42181103

NIH funding

U10HD021410 (1), U10HD027869 (1), U10HD027915 (1), U10HD027917 (1), U10HD034116 (1), U10HD034136 (1), U10HD034208 (1), U10HD036801 (1), U10HD040485 (1), U10HD040500 (1), U10HD040512 (1), U10HD040544 (1), U10HD040545 (1), U10HD040560 (1), U10HD053097 (1)